Many immunotherapy approaches use a STING agonist, such as liposomal CpG for use in colon cancer and melanoma,154, 162 liposomal cyclic diguanylate (di‐GMP) in melanoma,161, 167, 187 and liposomal cGAMP for breast cancer.141. This evidence concerns the gene STING1 and melanoma.